Search the Newsreel

NIU Technologies (NIU) Financial Health: Profitability & Balance Sheet Analysis

NIU Technologies (NIU) currently has a financial score of 5.44, ranking 63 out of 69 in the Automobiles & Auto Parts industry, indicating robust financial status but low operating efficiency. The company recently reported a quarterly revenue of $133.75 million, showing a 41.49% year-over-year …

Ternium SA expected to post earnings of $1.25 a share - Earnings Preview

Ternium SA is projected to report earnings of $1.25 per share. This information comes from an earnings preview provided by Refinitiv. The article provides a brief outlook on the company's anticipated financial performance.

Mega Uranium Ltd. Revenue Breakdown – TSX:MGA

Is Ternium (NYSE:TX) Still Reasonable Or Is The Upside Priced In?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Ternium stock has delivered a strong 62.7% return over the past year, yet the current share price still sits at a discount to the intrinsic value estimate …

Tuniu Corporation Revenue Breakdown – NASDAQ:TOUR

NIU Technologies (NIU) Institutional Confidence

NIU Technologies (NIU) has an institutional shareholding score of 3.00, placing it 41st out of 69 in the Automobiles & Auto Parts industry. The latest institutional shareholding proportion is 21.86%, showing a 30.54% increase quarter-over-quarter. The largest institutional shareholder is James Simons, though several …

Why Uranium Royalty Corp. stock is gaining today

Fresenius Medical Care stock trades steadily as dialysis margins and turnaround plan shape investor focus

Fresenius Medical Care stock continues to reflect the company's operational recovery in its global dialysis business, driven by steady patient volumes, improved operating performance, and margin recovery. The company reported a 5% revenue increase in Q1 2026, reaching EUR 5.00 billion, and its transformation …

Friday 7/31 Insider Buying Report: PKBK, UROY

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Parke Bancorp, a filing with the …

Oppenheimer Adjusts Price Target on Genius Sports to $10 From $9, Maintains Outperform Rating

Oppenheimer has increased its price target for Genius Sports (NYSE:GENI) to $10 from $9, while reiterating an Outperform rating on the stock. This adjustment comes as the firm expects Genius Sports to benefit from higher advertising spending in the second half of the year. …

Wall Street Analysts See a 34.86% Upside in Definium Therapeutics, Inc. (DFTX): Can the Stock Really Move This High?

Definium Therapeutics, Inc. (DFTX) closed at $44.49, and Wall Street analysts project a 34.9% upside with a mean price target of $60. While price targets alone can be misleading, the strong agreement among analysts and a positive trend in earnings estimate revisions suggest potential …

Ternium to Report Q2 Earnings: What's in the Cards for the Stock?

Ternium (TX) is poised to release its second-quarter 2026 earnings, with an expected beat driven by margin gains from higher prices, demand recovery in Mexico, and stable consumption in Brazil. The company's Earnings ESP of +21.40% and Zacks Rank #3 suggest a strong likelihood …

Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate

U.S. FDA and EMA acceptance for review of Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, of intravenous vedolizumab biosimilar candidate, an integrin receptor antagonist. Vedolizumab targets inflammatory bowel diseases, including moderately to severely active ulcerative colitis and Crohn's disease in adults. …

Ternium S.A. (NYSE:TX) Receives Average Rating of "Moderate Buy" from Analysts

Ternium S.A. (NYSE:TX) has received a "Moderate Buy" consensus rating from eleven analysts, with an average 12-month price target of $47.94. The company's shares opened at $49.11,

National Aluminium Company shares rise 2.06%

Vedanta Aluminium share price targets: Buy VAML stock, says Citi, Investec, Nuvama, MOFSL, Emkay post Q1 results

IsoEnergy Backs Orpheus Uranium (ASX:ORP) Capital Raise - Smart Money or an Early Signal?

Uranium Royalty Corp. SEC Filing (Jul 30, 2026)

Uranium Royalty Corp. (NASDAQ: UROY) filed a Form 15-12G with the SEC on July 30, 2026, certifying termination of registration under Section 12(g) and suspension of duty to file reports under Sections 13 and 15(d) of the Securities Exchange Act of 1934. The filing …

Die Fresenius-Medical-Care-Aktie zeigt Stabilität nach jüngsten Quartalszahlen

Uranium Royalty Corp. (A42EGZ) Company Information

This article provides detailed company information for Uranium Royalty Corp. (A42EGZ), including its market capitalization, industry, sector, employee information, and exchange listings on TSX, DB, and NasdaqCM. It also outlines the data sources and analysis model used by Simply Wall St for their reports, …

Uranium Royalty Corp (UROY) CEO Scott Melbye Buys 13,850 Shares

Uranium Royalty Corp (UROY) CEO Scott Melbye recently purchased 13,850 shares, increasing his direct ownership to 615,898 shares. This insider buying, combined with the stock trading below its intrinsic value according to GuruFocus's GF Value model, suggests a strong bullish outlook from management. The …

Tuniu Corp (TOUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Tuniu Corp (TOUR), detailing its price momentum, support and resistance levels, and various technical indicators like MACD, RSI, and moving averages. As of July 31, 2026, TOUR's price momentum score is 2.78, indicating it's suitable for range-bound …

NIU Technologies (NIU) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of NIU Technologies (NIU), detailing its current price momentum, support and resistance levels, and various technical indicators and moving averages. The analysis shows NIU's price momentum score is 5.09, suggesting it is suitable for range-bound swing trading between …

Fresenius (XTRA:FRE) Stock May Still Be Cheap On Its 66% Run

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Fresenius SE KGaA has delivered a 65.9% return over the past three years, yet the stock still screens as undervalued on Simply Wall St's …

Press Release: Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026

Definium Therapeutics announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026. The company will also host a conference call and webcast on the same day to discuss the results and provide a business update.

Definium Therapeutics Will Webcast Its Second-Quarter Update Aug. 6

Form 4 Uranium Royalty Corp. For: 30 July By Investing.com

This article announces the filing of Form 4 by Uranium Royalty Corp. on July 30. It is a brief announcement from Investing.com, providing no further details about the content of the Form 4 filing itself. The article highlights the company's stock symbol URC and …

Niu Technologies (NIU) Stock Price | Live Quotes & Charts | NASDAQ

This page provides live stock quotes and charts for Niu Technologies (NIU) on NASDAQ, showing a current price of $2.59 with a slight decrease. It indicates that there are no analyst ratings or earnings information currently available for the company. The page also features …

Definium Therapeutics (DFTX) Redefines Depression & Anxiety Treatment

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for "Meridian Small Cap Growth Fund". A copy of the letter can be downloaded here. The U.S. market saw a strong rally in the second quarter, fueled by easing geopolitical tensions, falling …

Uranium Royalty (NASDAQ:UROY) Coverage Initiated at National Bank Financial

National Bank Financial initiated coverage on Uranium Royalty (NASDAQ:UROY) with an "outperform" rating and a $3.75 price target, suggesting a 23.76% upside. This positive sentiment aligns with the consensus "Buy" rating and average price target of $4.12 for UROY shares. The stock rose 9.0% …

BNP Paribas Exane Upgrades Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) to "Strong Sell"

BNP Paribas Exane has downgraded Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) to a "strong sell" rating. This decision contributes to a cautious analyst sentiment, with the company currently holding an average "Reduce" rating and a consensus price target of $23.95. Despite some …

Fresenius Medical Care Number of Employees 2026 | Employee Count & Headcount Data

Fresenius Medical Care AG (FME) had approximately 110,828 total employees worldwide as of March 2026, marking a 3.6% decline since 2023. The company, headquartered in Germany, is actively hiring with 5,692 job postings in 2026, despite a significant year-over-year decline in new postings. Its …

NIU Technologies (NIU) Valuation: PE, PB & Fair Value Analysis

NIU Technologies (NIU) currently holds a valuation score of 7.21, placing it 59th out of 69 in the Automobiles & Auto Parts industry. The company's P/E ratio stands at -36.16, significantly below its recent high and above its recent low. Important valuation metrics like …

Vedanta Aluminium Q1 Results: Stock jumps 3% from lows on strong operating performance

Vedanta Aluminium Q1 Results: Net profit soars 3x YoY to Rs 5,629 crore; Rs 8/share dividend declared

Vedanta Aluminium Q1 PAT up threefold to `6,597 crore